Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Common Variants Associated With OSMR Expression Contribute to Carotid Plaque Vulnerability, but Not to Cardiovascular Disease in Humans.
van Keulen D, van Koeverden ID, Boltjes A, Princen HMG, van Gool AJ, de Borst GJ, Asselbergs FW, Tempel D, Pasterkamp G, van der Laan SW. van Keulen D, et al. Among authors: van gool aj, van koeverden id, van der laan sw. Front Cardiovasc Med. 2021 Apr 20;8:658915. doi: 10.3389/fcvm.2021.658915. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33959646 Free PMC article.
Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.
Keulen DV, Pouwer MG, Emilsson V, Matic LP, Pieterman EJ, Hedin U, Gudnason V, Jennings LL, Holmstrøm K, Nielsen BS, Pasterkamp G, Lindeman JHN, van Gool AJ, Sollewijn Gelpke MD, Princen HMG, Tempel D. Keulen DV, et al. Among authors: van gool aj. PLoS One. 2019 Aug 28;14(8):e0221477. doi: 10.1371/journal.pone.0221477. eCollection 2019. PLoS One. 2019. PMID: 31461490 Free PMC article.
Qualitative evaluation of coronary atherosclerosis in a large cohort of young and middle-aged Dutch tissue donors implies that coronary thrombo-embolic manifestations are stochastic.
Lindeman JH, Hulsbos L, van den Bogaerdt AJ, Geerts M, van Gool AJ, Hamming JF, van Dijk RA, Schaapherder AF. Lindeman JH, et al. Among authors: van gool aj, van dijk ra, van den bogaerdt aj. PLoS One. 2018 Nov 27;13(11):e0207943. doi: 10.1371/journal.pone.0207943. eCollection 2018. PLoS One. 2018. PMID: 30481212 Free PMC article.
Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population.
Sokooti S, Kieneker LM, Borst MH, Muller Kobold A, Kootstra-Ros JE, Gloerich J, van Gool AJ, Heerspink HJL, T Gansevoort R, Dullaart RPF, Bakker SJL. Sokooti S, et al. Among authors: van gool aj. J Clin Med. 2020 Sep 17;9(9):3001. doi: 10.3390/jcm9093001. J Clin Med. 2020. PMID: 32957570 Free PMC article.
The future of protein biomarker research in type 2 diabetes mellitus.
Tans R, Verschuren L, Wessels HJCT, Bakker SJL, Tack CJ, Gloerich J, van Gool AJ. Tans R, et al. Among authors: van gool aj. Expert Rev Proteomics. 2019 Feb;16(2):105-115. doi: 10.1080/14789450.2018.1551134. Epub 2018 Nov 27. Expert Rev Proteomics. 2019. PMID: 30468403
Clinical biomarker innovation: when is it worthwhile?
Kluytmans A, Deinum J, Jenniskens K, van Herwaarden AE, Gloerich J, van Gool AJ, van der Wilt GJ, Grutters JPC. Kluytmans A, et al. Among authors: van herwaarden ae, van gool aj, van der wilt gj. Clin Chem Lab Med. 2019 Oct 25;57(11):1712-1720. doi: 10.1515/cclm-2019-0098. Clin Chem Lab Med. 2019. PMID: 31287794 Free article.
88 results